跳至主要内容
临床试验/NCT06474845
NCT06474845终止不适用

Multicentre International Randomized Clinical Study to Assess the Efficacy of the T-Control® Catheter vs. a Conventional Foley-type Catheter

Rethink Medical SL12 个研究点 分布在 2 个国家目标入组 12 人开始时间: 2024年2月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
12
试验地点
12
主要终点
Rate of Catheter-Associated Urinary Tract Infections (symptomatic and asymptomatic)

研究概览

简要总结

The goal of this clinical trial is to learn if the new urinary catheter T-Control® allows a reduction in infections associated with urinary catheters and a better quality of life of urinary catheter patients compared to the conventional Foley-type catheter (the currently used in clinical practice). It will also learn about the safety profile of the T-Control® catheter and its cost-effectiveness. The main questions it aims to answer are:

Does the T-Control® catheter lower the number of infections of the patients who need long-term catheterization? Does he T-Control® catheter implies a better perceived quality of life of long-term catheterization patients?

Participants will:

Be catheterized with T-Control® or Foley catheter. Visit the clinic after 4 weeks for checkups, fullfill questionnaires and tests. Keep a diary of their symptoms and adverse events related to the catheter.

详细描述

This is a comparative, randomized, controlled, multicentric clinical study with two arms in which the T-control® catheter is compared with a conventional Foley-type catheter.

The main objective of this study is to determine the efficacy of T-Control® compared to the conventional Foley-type catheter, by comparing the number of CAUTIs (both symptomatic and asymptomatic) in patients with long-term catheterization. While the secondary objectives are: to determine the Health-related QoL (HRQoL) and analyze the self-perceived QoL of catheterized patients, as well as the acceptability of the T-Control® device, patient's satisfaction and patients' experience framed in the trajectory of the disease; to compare the safety profile between T-Control® and the conventional Foley-type catheter and the antibiotics used; to determine the cost-effectiveness of T-Control® versus the conventional Foley-type catheter, from the perspective of the hospital; and to measure the level of satisfaction of healthcare professionals with the different types of urinary catheters.

Follow-up includes both the time of the catheter insertion until its removal or change, lasting 4 weeks. All the parameters collected during the follow-up visit refer to the 4 weeks during which the patient has had the catheter inserted.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

盲法说明

Due to the nature of the intervention, it is not possible to blind the patient or the healthcare professional; however, the professional who analyses the data will be unaware of the type of catheter used for each patient.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women aged ≥18 years
  • Patients who require change of bladder catheter.
  • Patients with indication of bladder catheterization for at least 4 weeks.
  • Patients who maintain cognitive and physical ability for self-monitoring of the catheter valve.
  • Patients who sign ICF prior to the performance of any study-specific procedure.

排除标准

  • Use of current antibiotic treatment or in the 2 weeks prior to the study inclusion.
  • Patients undergoing chemotherapy, radiotherapy, immunosuppressants or retroviral treatment.
  • Patients with bilateral obstructive supravesical uropathy.
  • Inability to read and understand the language of the Hospital's country.
  • Patients who are participating in a clinical trial or intends to participate during the course of this study.

研究组 & 干预措施

Experimental arm (T-Control®)

Experimental

Patients catheterized with a catheter with a control valve for intermittent drainage

干预措施: T-Control® catheter (Device)

Control arm (Foley)

Active Comparator

Patients catheterized with a conventional urinary catheter with continuous drainage

干预措施: Foley-type catheter (Device)

结局指标

主要结局

Rate of Catheter-Associated Urinary Tract Infections (symptomatic and asymptomatic)

时间窗: 4 weeks

Number of infections divided by number of patients. The presence of pathogenic microorganisms in quantities greater than or equal to 1,000 CFU/ml will determine the presence of infection, while, in the absence of symptoms of infection, a determination of microorganisms greater than or equal to 100,000 CFU/ml will indicate asymptomatic infection.

Magnitude of Catheter-Associated Urinary Tract Infections (symptomatic and asymptomatic)

时间窗: 4 weeks

Amount of pathogenic microorganisms present in urine (in CFU/ml) divided by number of patients

次要结局

  • Cost-effectiveness(4 weeks)
  • Antibiotic treatments(4 weeks)
  • Satisfaction of health professionals(9 months)
  • Health Related Quality of Life (HRQoL)(4 weeks)
  • Adverse events(4 weeks)
  • Catheter Related Quality of Life(4 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验